Danaparoid

Orgaran

750 UNIT / 0.6 ML SolutionCanadaMarketedAuthorised 31 Dec 1995

In other countries

The same active substances on other registers, the same brand first.

Orgaran, 750 anti-Xa eenheden, oplossing voor injectieNetherlands · Oplossing voor injectie · Viatris Healthcare LimitedSame brand
OrgaranUnited States · 750 UNITS/0.6ML · injectable · Aspen Global INCSame brand
Traleusin 750 U Anti-Xa/0,6 ML Solucion Inyectable y Para PerfusionSpain · 1.250 anti-Xa UI/ml · solucion inyectable y para perfusion · Viatris LimitedSame substance
TraleusinItaly · Soluzione iniettabile · Viatris Italia S.R.L.Same substance
Danaparoid natrium Viatris, 750 anti-Xa eenheden/0,6 ml, oplossing voor injectie/infusieNetherlands · Oplossing voor injectie of infusie · Viatris LimitedSame substance
Danaparoid natrium Viatris, 750 anti-Xa-eenheden, oplossing voor injectie

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Danaparoid

Orgaran

750 UNIT / 0.6 ML SolutionCanadaMarketedAuthorised 31 Dec 1995

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Netherlands · Oplossing voor injectie · Viatris Limited

AnyNew Zealand · Inj 750 u in 0.6 ml ampoule

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Danaparoid
Strength: 750 UNIT / 0.6 ML
Dosage form: Solution
Route: Intravenous, Subcutaneous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 31 Dec 1995
Registration: DIN 02129043
Marketing authorisation holder: Aspen Pharmacare Canada INC.
ATC code: B01AB09
Group: Blood and blood-forming organs
Supply: PRESCRIPTION